Intervention Review

Pycnogenol® (extract of French maritime pine bark) for the treatment of chronic disorders

  1. Anel Schoonees1,
  2. Janicke Visser1,
  3. Alfred Musekiwa2,
  4. Jimmy Volmink3,4,*

Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group

Published Online: 18 APR 2012

Assessed as up-to-date: 6 DEC 2011

DOI: 10.1002/14651858.CD008294.pub4


How to Cite

Schoonees A, Visser J, Musekiwa A, Volmink J. Pycnogenol® (extract of French maritime pine bark) for the treatment of chronic disorders. Cochrane Database of Systematic Reviews 2012, Issue 4. Art. No.: CD008294. DOI: 10.1002/14651858.CD008294.pub4.

Author Information

  1. 1

    Stellenbosch University, Division of Human Nutrition, Tygerberg, Western Cape, South Africa

  2. 2

    University of the Witwatersrand, Wits Reproductive Health and HIV Institute (WRHI), Faculty of Health Sciences, Johannesburg, South Africa

  3. 3

    Stellenbosch University, Faculty of Medicine and Health Sciences, Tygerberg, South Africa

  4. 4

    South African Medical Research Council, South African Cochrane Centre, Tygerberg, Western Cape, South Africa

*Jimmy Volmink, jvolmink@sun.ac.za.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 18 APR 2012

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Mohammad Moshahid Khan, Duraisamy Kempuraj, Ramasamy Thangavel, Asgar Zaheer, Protection of MPTP-induced neuroinflammation and neurodegeneration by Pycnogenol, Neurochemistry International, 2013, 62, 4, 379

    CrossRef